PROTOCOL FOR THE IN-HOUSE PRODUCTION OF FFP-LR240-DERIVED CRYOPRECIPITATE-Reference-Cited by-同舟云学术

PROTOCOL FOR THE IN-HOUSE PRODUCTION OF FFP-LR240-DERIVED CRYOPRECIPITATE

Published:2019-02-28 Issue:1 Volume:65 Page:10-20
ISSN:1881-3011
Container-title:Japanese Journal of Transfusion and Cell Therapy
language:en
Short-container-title:JJTC

Author:

Ohishi Kohshi¹²,Matsumoto Takeshi¹²,Tanaka Yumi¹,Iwao Noriaki³²,Kato Hidefumi⁴²,Takeshita Akihiro⁵²,Tamaki Shigehisa⁶²,Fujii Satoshi⁷⁸²,Fujimori Yoshihiro⁹²,Makino Shigeyoshi¹⁰²,Yamamoto Koji¹¹²,Ikemoto Junko⁹,Otsuka Kohei⁸,Hoshino Koji¹²,Miyazaki Kenichi¹³,Mori Keiko⁶,Yamada Chiaki⁵,Miyata Shigeki¹⁴²

Affiliation:

1. Transfusion Medicine and Cell Therapy, Mie University Hospital

2. ‌Task Force on Standardized Methods for In-house Cryoprecipitate Production, Committee on Appropriate Blood Product Modifications. The Japan Society of Transfusion Medicine and Cell Therapy

3. Department of Hematology, Juntendo University Shizuoka Hospital

4. Department of Transfusion Medicine, Cell Therapy Center, Aichi Medical University Hospital

5. Transfusion and Cell Therapy, Hamamatsu University School of Medicine

6. Department of Blood Transfusion and Cell Therapy, Ise Red Cross Hospital

7. Department of Laboratory Medicine, Asahikawa Medical University

8. Medical Laboratory and Transfusion Center, Asahikawa Medical University Hospital

9. Center for Transfusion Medicine and Cellular Therapy, Hyogo College of Medicine Hospital

10. Department of Transfusion Medicine, Toranomon Hospital

11. Department of Transfusion Medicine and Cell Therapy, Saitama Medical Center, Saitama Medical University

12. Transfusion Service, Okazaki City Hospital

13. Department of Central Clinical Laboratory, Yaizu City Hospital

14. Department of Clinical Laboratory Medicine, National Cerebral and Cardiovascular Center

Publisher

Japan Society of Transfusion Medicine and Cell Therapy

Subject

Computer Networks and Communications,Hardware and Architecture,Software

Link

https://www.jstage.jst.go.jp/article/jjtc/65/1/65_10/_pdf

Reference8 articles.

1. 1) Rossaint R, Bouillon B, Cerny V, et al: The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care, 20: 100, 2016.

2. 2) Fries D, Martini WZ: Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth, 105: 116-121, 2010.

3. 3) Charbit B, Mandelbrot L, Samain E, et al: The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost, 5: 266-273, 2007.

4. 4) Gielen C, Dekkers O, Stijnen T, et al: The effects of pre- and postoperative fibrinogen levels on blood loss after cardiac surgery: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg, 18: 292-298, 2014.

5. 5) 日本医療研究開発機構 (AMED) 医薬品等規制調和・評価研究事業「大量出血症例に対する血液製剤の適正な使用のガイドライン作成に関する研究」研究班 (研究開発代表者宮田茂樹): 大量出血症例に対する血液製剤の適正な使用のガイドライン. http://yuketsu.jstmct.or.jp/medical/public_comment/

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HEMOSTATIC TREATMENT USING CRYOPRECIPITATE OR FIBRINOGEN CONCENTRATE FOR CRITICAL MASSIVE BLEEDING;Japanese Journal of Transfusion and Cell Therapy;2021-12-24